Takeda eyes vaccine business growth as dengue, COVID-19 shots progress – CEO
akeda Pharmaceutical Co (4502.T), which distributes Moderna Inc's (MRNA.O) COVID-19 shots in Japan, expects vaccines to become a bigger part of its portfolio
Please be informed that a specific anonymous source is attempting a cyber-attack to damage the reputation of World Economic Magazine. They might attempt to access your personal or professional email under the guise of making untrue accusations against our company via email, the internet, etc. You are urged to use extreme caution when receiving such emails because these statements are false and fraudulent.
Please note that we never owed any monetary dues to any party whatsoever. Any agency or source claiming otherwise, is doing so solely with a deceitful intention and is a part of fraudulent activities
akeda Pharmaceutical Co (4502.T), which distributes Moderna Inc's (MRNA.O) COVID-19 shots in Japan, expects vaccines to become a bigger part of its portfolio
Small-time stock traders turned their attention to the biotech and healthcare sectors on Monday, lifting shares of some by as